Clinical Trial Update: The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Nebido (testosterone undecanoate) as monotherapy or with PDE-5 inhibitors for erectile dysfunction in hypogonadal men; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Hypogonadism

Drugs mentioned

• Nebido (testosterone undecanoate)

Snippet

Sponsor: Chulalongkorn University | Conditions: Hypogonadism, Erectile Dysfunction | Phase 4 | Status: COMPLETED